However, this was somewhere neglected until the recent discovery that the first enzyme of SSP, phosphoglycerate dehydrogenase (PHGDH), is genetically amplified in breast cancer and melanoma (149, 150), and overexpression of the SSP components are correlated with poorer prognosis in breast cancer patients (151). This evidence concerns the gene PHGDH and breast cancer.